Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Series B Convertible Preferred stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Total Equity Attributable to HOFRE Stockholders	Non-controlling Interest	Total
Balance at Dec. 31, 2019		$ 544		$ 34,948,795	$ 34,949,339		$ 34,949,339
Balance (in Shares) at Dec. 31, 2019		5,436,000
Contribution from shareholders				3,699,000	3,699,000		3,699,000
Conversion of the preferred equity loan		$ 1,228	58,438,346		58,439,574		58,439,574
Conversion of the preferred equity loan (in Shares)		12,277,428
Shares of common stock issued for accounts payable and due to affiliates		$ 229	23,425,932		23,426,161		23,426,161
Shares of common stock issued for accounts payable and due to affiliates (in Shares)		2,292,624
Business combination with GPAQ on July 1, 2020		$ 653	494,179		494,832		494,832
Business combination with GPAQ on July 1, 2020 (in Shares)		6,538,201
Shares of common stock issued in exchange of debt		$ 1,609	54,516,767		54,518,376		54,518,376
Shares of common stock issued in exchange of debt (in Shares)		16,093,857
Stock-based compensation on restricted stock awards		$ 72	2,772,733		2,772,805		2,772,805
Stock-based compensation on restricted stock awards (in Shares)		715,929
Stock-based compensation on restricted stock units			1,554,968		1,554,968		1,554,968
Vesting of restricted stock units		$ 18	(18)
Vesting of restricted stock units (in Shares)		176,514
Stock-based compensation - common stock awards		$ 3	195,997		196,000		196,000
Stock-based compensation - common stock awards (in Shares)		25,000
Contingent beneficial conversion feature on PIPE Notes			14,166,339		14,166,339		14,166,339
November 18, 2020 capital raise, net of offering costs		$ 1,786	14,476,624		14,478,410		14,478,410
November 18, 2020 capital raise, net of offering costs (in Shares)		17,857,142
December 4, 2020 capital raise, net of offering costs		$ 268	2,070,821		2,071,089		2,071,089
December 4, 2020 capital raise, net of offering costs (in Shares)		2,678,571
Net loss				(45,488,666)	(45,488,666)	(196,506)	(45,685,172)
Balance at Dec. 31, 2020		$ 6,410	172,112,688	(6,840,871)	165,278,227	(196,506)	165,081,721
Balance (in Shares) at Dec. 31, 2020		64,091,266
Stock-based compensation on restricted stock units (“RSU”) and restricted stock awards (“RSA”)			5,510,134		5,510,134		5,510,134
Stock-based compensation - common stock awards		$ 2	72,498		72,500		72,500
Stock-based compensation - common stock awards (in Shares)		25,000
February 12, 2021 Capital Raise, net of offering costs		$ 1,224	27,560,774		27,561,998		27,561,998
February 12, 2021 Capital Raise, net of offering costs (in Shares)		12,244,897
February 18, 2021 Overallotment, net of offering costs		$ 184	4,184,814		4,184,998		4,184,998
February 18, 2021 Overallotment, net of offering costs (in Shares)		1,836,734
Issuance of vested RSUs		$ 2	(2)
Issuance of vested RSUs (in Shares)		24,028
Issuance of vested RSAs		$ 6	(6)
Issuance of vested RSAs (in Shares)		66,451
Sale of Series B preferred stock and warrants	$ 2		15,199,998		15,200,000		15,200,000
Sale of Series B preferred stock and warrants (in Shares)	15,200
Vesting of RSUs, net of tax		$ 84	(84)
Vesting of RSUs, net of tax (in Shares)		841,218
Exercise of Warrants		$ 1,678	77,002,464		77,004,142		77,004,142
Exercise of Warrants (in Shares)		16,775,143
Sale of common stock under at the market offering		$ 166	3,473,813		3,473,979		3,473,979
Sale of common stock under at the market offering (in Shares)		1,659,104
Series B preferred stock dividends				(697,575)	(697,575)		(697,575)
Net loss				(92,413,393)	(92,413,393)	(400,260)	(92,813,653)
Balance at Dec. 31, 2021	$ 2	$ 9,756	$ 305,117,091	$ (99,951,839)	$ 205,175,010	$ (596,766)	$ 204,578,244
Balance (in Shares) at Dec. 31, 2021	15,200	97,563,841